Specialty Ophthalmology
-
Featured
Researchers Find Potential Path to a Broadly Protective COVID-19 Vaccine Using T cells
Gaurav Gaiha, MD, DPhil, and Elizabeth Rossin, MD, PhD, use structure-based network analysis to confirm predictions about the potential for a T cell vaccine that provides protection against existing variants, such as the Delta variant, and future SARS-CoV-2 variants.
-
Featured
Using Artificial Intelligence to Diagnose Glaucoma
David S. Friedman, MD, PhD, MPH, a clinician-scientist and director of the Glaucoma Service in the Department of Ophthalmology, discusses the implementation of artificial intelligence in the detection of glaucoma in screening with photographs.
-
Featured
Potential Treatment Targets Identified for Age-Related Macular Degeneration
By assessing genomic–metabolomic associations in age-related macular degeneration, Deeba Husain, MD, of the Department of Ophthalmology, and colleagues have obtained additional evidence of the pathogenic role of the LIPC gene and glycerophospholipid metabolism, which may represent novel treatment targets.
-
Review: Telemedicine for Diagnosis and Management of Age-Related Macular Degeneration
John B. Miller, MD, and Grayson W. Armstrong, MD, MPH, of the Mass Eye and Ear Department of Ophthalmology report that advances in telemedicine allow for remote screening for AMD, electronic consultations between comprehensive ophthalmologists and retina specialists, and home-based disease monitoring.
-
Use of "Light Pipe" During Endoscopic Dacryocystorhinostomy No Substitute for Landmark-based Surgery
Daniel R. Lefebvre, MD, an oculoplastic surgeon in the Department of Ophthalmology, and colleagues caution surgeons transitioning to endoscopic dacryocystorhinostomy that use of an endocanalicular "light pipe" while becoming familiar with intranasal anatomy may lead to an osteotomy that is undersized and too posterior.
-
Ophthalmic Telemedicine Can Exacerbate Health Inequalities
Grayson W. Armstrong, MD, MPH, and colleagues noted demographic disparities of patients who received ophthalmic telemedicine at Mass Eye and Ear during the first year of COVID-19. Patients who were Black, male, did not speak English, did not attain higher education and were older were less likely to get virtual care.
Ophthalmology Contributors
-
Alice C. Lorch, MD, MPH
Assistant Professor of Ophthalmology, Harvard Medical School, Associate Chief for Quality for the Department of Ophthalmology, Mass Eye and Ear, Director, Harvard Ophthalmology Residency Training Program
Recent Article
Minimally Invasive Glaucoma Surgery Has Been Adopted Rapidly in the U.S.
-
Bruce Ksander, PhD
Associate Professor of Ophthalmology, Harvard Medical School, Associate Scientist, Mass Eye and Ear
Recent Article
Turning Back the Clock on Aged Eye Cells
-
Janey L. Wiggs, MD, PhD
Associate Chief, Ophthalmology Clinical Research, Mass Eye and Ear, Paul Austin Chandler Professor of Ophthalmology, Harvard Medical School
Recent Article
Genetic Risk Factor for Alzheimer's Disease Linked to Reduced Glaucoma Risk
-
Joan W. Miller, MD
Chief, Ophthalmology Department, Massachusetts General Hospital, Chief, Ophthalmology Department, Mass Eye and Ear, Ophthalmologist-in-Chief, Brigham and Women’s Hospital
Recent Article
Minimally Invasive Glaucoma Surgery Has Been Adopted Rapidly in the U.S.
-
John B. Miller, MD
Director, Retinal Imaging, Mass Eye and Ear, Associate Director, Vitreoretinal Fellowship, Assistant Professor of Ophthalmology, Harvard Medical School
Recent Article
Review: Telemedicine for Diagnosis and Management of Age-Related Macular Degeneration
-
Lucia Sobrin, MD, MPH
Associate Chief of Clinical Data Science and Director of the Morse Laser Center, Mass Eye and Ear, Associate Professor of Ophthalmology, Harvard Medical School, Co-Director, Ocular Immunology and Uveitis Fellowship
Recent Article
Female Hormonal Therapy Makes Only Small Contribution to Risk of Noninfectious Uveitis
-
Luk Vandenberghe, PhD
Associate Professor of Ophthalmology, Harvard Medical School, Grousbeck Family Chair in Gene Therapy and Director of the Grousbeck Gene Therapy Center, Mass Eye and Ear
Recent Article
Developing a Gene-based Vaccine Candidate for COVID-19
-
Meredith Gregory-Ksander, PhD
Associate Scientist, Schepens Eye Research Institute, Mass Eye and Ear, Assistant Professor of Ophthalmology, Harvard Medical School
Recent Article
Turning Back the Clock on Aged Eye Cells
-
Milica Margeta, MD, PhD
Assistant Professor of Ophthalmology, Harvard Medical School, Assistant Scientist, Mass Eye and Ear
Recent Article
Genetic Risk Factor for Alzheimer's Disease Linked to Reduced Glaucoma Risk
-
Nazlee Zebardast, MD, MSc
Director, Glaucoma Imaging, Mass Eye and Ear/Massachusetts General Hospital Department of Ophthalmology, Assistant Professor, Ophthalmology, Harvard Medical School
Recent Article
Minimally Invasive Glaucoma Surgery Has Been Adopted Rapidly in the U.S.
-
Tobias Elze, PhD
Assistant Professor of Ophthalmology, Harvard Medical School, Assistant Scientist, Mass Eye and Ear
Recent Article
Laterality of Retinal Vascular Occlusion Depends on Subtype
-
Ula V. Jurkunas, MD
Associate Professor of Ophthalmology, Harvard Medical School, Associate Scientist, Mass Eye and Ear
Mass Eye and Ear/Mass General Ophthalmology
An international center for ophthalmology treatment and research, Mass Eye and Ear/Massachusetts General Hospital is the primary teaching hospital of Harvard Medical School’s Department of Ophthalmology, and is consistently recognized as one of the nation’s top hospitals for eye care. Led by Chief and Chair Joan W. Miller, MD, the department provides seamless access to the most innovative care available anywhere in the world.
